Näytetään tulokset 1 - 10 / 8431
tulosta / sivu
Mitä julkaisutietoja palvelu sisältää?
Julkaisun nimi
Tekijät
Julkaisukanava
Vuosi
 Julkaisujen tiedon ikoni

Novel therapeutic approaches for pleural mesothelioma identified by functional ex vivo drug sensitivity testing

Vertaisarvioitu
Avoin saatavuus
DOI
10.1016/j.lungcan.2023.02.024
Ollila-Raj, Hely; Murumägi, Astrid; Pellinen, Teijo; Arjama, Mariliina; Sutinen, Eva; Volmonen, Kirs...
Lung cancer2023 Julkaisujen tiedon ikoni

Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment

Vertaisarvioitu
Avoin saatavuus
DOI
10.1186/s40169-019-0253-6
Skaga, Erlend; Kulesskiy, Evgeny; Brynjulvsen, Marit; Sandberg, Cecilie J; Potdar, Swapnil; Langmoen...
Clinical and translational medicine2019 Julkaisujen tiedon ikoni

Comparison of two supporting matrices for patient-derived cancer cells in 3D drug sensitivity and resistance testing assay (3D-DSRT)

Vertaisarvioitu
Avoin saatavuus
DOI
10.1016/j.slasd.2023.03.002
Feoforoff, Michaela; Mikkonen, Piia; Turunen, Laura; Hassinen, Antti; Paasonen, Lauri; Paavolainen, ...
SLAS discovery2023 Julkaisujen tiedon ikoni

Protocol for 3D drug sensitivity and resistance testing of patient-derived cancer cells in 384-well plates

Vertaisarvioitu
Avoin saatavuus
DOI
10.1016/j.slasd.2022.11.003
Feodoroff, Michaela Josefine; Mikkonen, Piia; Arjama, Mariliina; Murumägi, Astrid; Kallioniemi, Olli...
SLAS discovery2023 Julkaisujen tiedon ikoni

Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing

Vertaisarvioitu
Avoin saatavuus
DOI
10.18632/oncotarget.17630
Majumder, Muntasir Mamun; Silvennoinen, Raija; Anttila, Pekka; Tamborero, David; Eldfors, Samuli; Ya...
Oncotarget2017 Julkaisujen tiedon ikoni

Integrated analysis of drug sensitivity and selectivity to predict synergistic drug combinations and target coaddictions in cancer

Vertaisarvioitu
Avoin saatavuus
DOI
10.1007/978-1-4939-8891-4_12
Jaiswal, Alok; Yadav, Bhagwan; Wennerberg, Krister; Aittokallio, Tero
Methods in molecular biology2019 Julkaisujen tiedon ikoni

Efficient differentially private learning improves drug sensitivity prediction

Vertaisarvioitu
Avoin saatavuus
DOI
10.1186/s13062-017-0203-4
Honkela, Antti; Das, Mrinal; Nieminen, Arttu; Dikmen, Onur; Kaski, Samuel
Biology direct2018 Julkaisujen tiedon ikoni

Evaluation of statistical approaches for association testing in noisy drug screening data

Vertaisarvioitu
Avoin saatavuus
DOI
10.1186/s12859-022-04693-z
Smirnov, Petr; Smith, Ian; Safikhani, Zhaleh; Ba-alawi, Wail; Khodakarami, Farnoosh; Lin, Eva; Yu, Y...
BMC Bioinformatics2022 Julkaisujen tiedon ikoni

Characterization of mature T-cell leukemias by next-generation sequencing and drug sensitivity testing

Avoin saatavuus
Andersson, Emma
Dissertationes Scholae Doctoralis Ad Sanitatem Investigandam Universitatis Helsinkiensis2017 Julkaisujen tiedon ikoni

Acquired drug resistance during the turnaround time for drug susceptibility testing impacts outcome of tuberculosis

Vertaisarvioitu
DOI
10.1016/j.tube.2023.102341
Zhu, Jiahui; Liu, Jia; Bao, Ziwei; Cao, Hong; Wang, Sainan; Li, Xuliang; Ning, Zhu; Hoffner, Sven; H...
Tuberculosis2023

Novel therapeutic approaches for pleural mesothelioma identified by functional ex vivo drug sensitivity testing

Vertaisarvioitu
Avoin saatavuus
DOI
10.1016/j.lungcan.2023.02.024
2023

Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment

Vertaisarvioitu
Avoin saatavuus
DOI
10.1186/s40169-019-0253-6
2019

Comparison of two supporting matrices for patient-derived cancer cells in 3D drug sensitivity and resistance testing assay (3D-DSRT)

Vertaisarvioitu
Avoin saatavuus
DOI
10.1016/j.slasd.2023.03.002
2023

Protocol for 3D drug sensitivity and resistance testing of patient-derived cancer cells in 384-well plates

Vertaisarvioitu
Avoin saatavuus
DOI
10.1016/j.slasd.2022.11.003
2023

Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing

Vertaisarvioitu
Avoin saatavuus
DOI
10.18632/oncotarget.17630
2017

Integrated analysis of drug sensitivity and selectivity to predict synergistic drug combinations and target coaddictions in cancer

Vertaisarvioitu
Avoin saatavuus
DOI
10.1007/978-1-4939-8891-4_12
2019

Efficient differentially private learning improves drug sensitivity prediction

Vertaisarvioitu
Avoin saatavuus
DOI
10.1186/s13062-017-0203-4
2018

Evaluation of statistical approaches for association testing in noisy drug screening data

Vertaisarvioitu
Avoin saatavuus
DOI
10.1186/s12859-022-04693-z
2022

Characterization of mature T-cell leukemias by next-generation sequencing and drug sensitivity testing

Avoin saatavuus
2017

Acquired drug resistance during the turnaround time for drug susceptibility testing impacts outcome of tuberculosis

Vertaisarvioitu
DOI
10.1016/j.tube.2023.102341
2023